If you own or operate a healthcare business, whether a physician practice, home health agency, hospice company, ambulatory surgery center, specialty pharmacy, or other healthcare enterprise, and are contemplating a sale in the next few years, one of the most impactful steps you can take to maximize the value of your business is a pre-sale compliance assessment. This is a structured review of the regulatory and operational issues that quietly erode business value during a transaction and addressing them early puts you in control of the narrative rather than reacting to a buyer's due diligence findings.
Too often, healthcare business owners enter a sale process without fully appreciating how compliance gaps look from the buyer's side of the table. What seems like a minor oversight to you, such as an outdated operating agreement or lease, an unresolved credit balance, a compensation arrangement that has drifted out of compliance, or a referral relationship that was never properly documented, can become a significant price-reduction lever once a buyer's legal due diligence teams start pulling threads. The good news is that most of these issues can be identified and resolved inexpensively well in advance of going to market.
How a Compliance Assessment Protects and Maximizes Valuation
A clean compliance profile commands premium value. Healthcare buyers are sophisticated and price risk aggressively. Unresolved compliance issues discovered during due diligence can become tools for re-trading purchase price, increasing escrow holdbacks or demanding broader indemnification obligations from the seller. In the worst case, they can derail a transaction altogether after the seller has invested considerable time, effort, and expense preparing for closing. Identifying and addressing compliance issues before going to market can reduce, or even eliminate, these potential sources of devaluation. Even if every issue cannot be fully resolved before closing, demonstrating a proactive commitment to remediation signals to buyers that the business is well-managed, compliance-focused, and committed to operational excellence.
A pre-sale compliance review can also accelerate the deal timeline. Transactions involving businesses that have already addressed common diligence issues typically close faster, experience less re-trading prior to closing, and incur lower professional fees because fewer hours are spent responding to buyer requests and negotiating around newly discovered problems.
Finally, even if you ultimately decide not to sell, you walk away with a documented compliance roadmap and meaningfully lower regulatory exposure.
What a Pre-Sale Compliance Assessment Should Cover
A thorough assessment should be drawn from a comprehensive healthcare diligence agenda, which is essentially the same areas a buyer's counsel will scrutinize, tailored to the specific regulatory landscape of your business type. Based on best practices, the common core areas include:
Corporate Structure and Agreements. This covers your operating and shareholder agreements (or LLC agreements, partnership agreements, and similar governance documents), ownership records, capitalization tables, management structure, and whether your entity is structured in a tax-efficient manner for a sale. Buyers will closely examine whether your governance documents are current, whether ownership interests, including transfers, are clearly documented, and whether there are any structural impediments to a clean transaction. For businesses with complex organizational charts, such as management companies (or MSOs) paired with professional entities, or multi-site operations under a holding company, ensuring structural clarity is especially critical.
Regulatory Compliance. This is often where the highest-risk issues live. A review should address compliance with the fraud and abuse laws (i.e., the Stark law, the Anti-Kickback Statute), HIPAA and privacy obligations, state licensure and certificate of need requirements specific to your business type, the existence and effectiveness of your compliance program, and OIG exclusion checks for all owners, employees, and contractors. A practical recommendation here is to conduct exclusion checks on a monthly basis going forward.
Licenses and Certifications. Confirm that all state licenses, DEA registrations (where applicable), permits, and accreditations are current and in good standing. Lapses in licensure, even if cured, create diligence questions that slow a transaction.
Payor Contracts and Reimbursement. Your Medicare and Medicaid enrollment and certification status, commercial payor agreements (including all amendments to these contracts), coding and billing practices, conditions of participation compliance (particularly relevant for home health and hospice providers), and any old credit balances owed to patients and payors should all be reviewed. Unresolved credit balances are a common diligence finding that buyers view as a red flag because they may create liability under state refund laws.
Employment and Compensation. Employment agreements for key clinical and administrative personnel, compensation arrangements, non-compete provisions, correct classification of independent contractor relationships, and benefit plan compliance all warrant careful review. Compensation arrangements that raise fair-market-value concerns under fraud and abuse laws are among the most common issues identified in healthcare transactions, and they are far easier to restructure proactively than to explain away during buyer diligence.
Real Estate and Leases. Facility leases, fair-market-value considerations for any related-party real estate transactions, and strategies for maximizing the value of owned real estate should all be evaluated. If you lease space from an owner or related entity, ensure the lease terms reflect fair market value and commercially reasonable terms as this is one of the first things a buyer's regulatory analysis will scrutinize.
Litigation and Disputes. Any pending or threatened litigation, payor audits, government investigations, and malpractice history should be cataloged and assessed. Buyers expect disclosure of these matters, and presenting them in an organized, contextualized manner, rather than having a buyer discover them piecemeal, reflects well on the seller and reduces perceived risk.
Insurance. Review your malpractice coverage, tail policy obligations, and property, casualty and general liability insurance. Understanding your tail exposure in advance is particularly important because it can directly affect deal economics. In many transactions, the cost of tail coverage is a negotiated item between buyer and seller. In addition, many buyers require sellers to maintain or obtain directors and officers (D&O) liability insurance before closing. Sellers should also consider obtaining cybersecurity insurance if they do not already have coverage in place.
Key Contracts, Leases and Vendor Agreements. Ancillary service agreements, equipment leases, IT and EHR system contracts, and any referral arrangements should be reviewed for assignment provisions, change of control triggers, and regulatory compliance.
Financial and Tax Matters. Tax compliance, retirement plan obligations, and outstanding liabilities are also critical to the assessment. Early coordination with tax advisors to model deal structures and with estate and wealth advisors to plan for receipt of proceeds can meaningfully improve after-tax outcomes.
Practical Recommendations for Sellers
Start early. The sooner you undertake a pre-sale compliance assessment prior to going to market, the better. As a seller, you want to have adequate time to remediate any issues without the pressure of a live transaction timeline. Rushed remediation during a deal process is expensive, stressful, and often incomplete.
Get a written action plan. The output of your assessment should be a written summary of identified compliance gaps with prioritized action items. This becomes your remediation roadmap. Prioritize items based on their likely impact on valuation and their complexity to resolve.
Implement selectively but strategically. Not every identified issue requires outside counsel to resolve. Many gaps (for example, updating exclusion check protocols, refreshing policies and procedures, organizing corporate records) can be handled internally once identified. Reserve outside legal engagement for issues that are highly sensitive or legally complicated.
Think like a buyer. Every item on the assessment checklist represents something a buyer's diligence team will eventually examine. The question is not whether these issues will surface, but whether they surface on your terms, already resolved, or on the buyer's terms, as negotiating leverage. Sellers who have invested the time to present a clean compliance profile consistently achieve stronger valuations, smoother transaction processes, and more favorable deal terms.
A pre-sale compliance assessment represents a modest upfront investment that is very likely to generate substantial returns when you ultimately transact. For healthcare business owners serious about maximizing the value of what they have built, it is one of the highest return on investment steps available in the pre-market preparation phase.
About The Author
Anjana Patel is a nationally recognized healthcare attorney and shareholder at Baker Donelson law firm in Princeton, New Jersey with more than 25 years of experience guiding health care providers, organizations, and investors through complex legal and business challenges. Known for her sharp strategic thinking and deep industry knowledge, Anjana is a trusted advisor to clients navigating today's dynamic health care landscape.
Connect with her on LinkedIn!
Learn more about Baker Donelson and all the ways they can help healthcare owners through a transaction!